Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Revenue: 2010-2024

Historic Revenue for Catalyst Pharmaceuticals (CPRX) over the last 8 years, with Dec 2024 value amounting to $491.7 million.

  • Catalyst Pharmaceuticals' Revenue rose 15.31% to $148.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $578.2 million, marking a year-over-year increase of 25.56%. This contributed to the annual value of $491.7 million for FY2024, which is 23.49% up from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Revenue stood at $491.7 million for FY2024, which was up 23.49% from $398.2 million recorded in FY2023.
  • Over the past 5 years, Catalyst Pharmaceuticals' Revenue peaked at $491.7 million during FY2024, and registered a low of $119.1 million during FY2020.
  • In the last 3 years, Catalyst Pharmaceuticals' Revenue had a median value of $398.2 million in 2023 and averaged $368.0 million.
  • Data for Catalyst Pharmaceuticals' Revenue shows a peak YoY skyrocketed of 85.90% (in 2023) over the last 5 years.
  • Catalyst Pharmaceuticals' Revenue (Yearly) stood at $119.1 million in 2020, then increased by 18.27% to $140.8 million in 2021, then soared by 52.10% to $214.2 million in 2022, then spiked by 85.90% to $398.2 million in 2023, then grew by 23.49% to $491.7 million in 2024.